BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36112043)

  • 1. Evaluation of Brain Tumors Using Amide Proton Transfer Imaging: A Comparison of Normal Amide Proton Transfer Signal With Abnormal Amide Proton Transfer Signal Value.
    Sugawara K; Miyati T; Wakabayashi H; Yoshimaru D; Komatsu S; Hagiwara K; Saigusa K; Ohno N
    J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):121-128. PubMed ID: 36112043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
    Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
    Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging.
    Zhou J; Blakeley JO; Hua J; Kim M; Laterra J; Pomper MG; van Zijl PC
    Magn Reson Med; 2008 Oct; 60(4):842-9. PubMed ID: 18816868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
    Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
    Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B
    Togao O; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Yoneyama M; Honda H
    Magn Reson Med; 2017 Jun; 77(6):2272-2279. PubMed ID: 27385636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
    Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
    Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scan-rescan reproducibility of parallel transmission based amide proton transfer imaging of brain tumors.
    Togao O; Hiwatashi A; Keupp J; Yamashita K; Kikuchi K; Yoshiura T; Suzuki Y; Kruiskamp MJ; Sagiyama K; Takahashi M; Honda H
    J Magn Reson Imaging; 2015 Nov; 42(5):1346-53. PubMed ID: 25828573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Amide Proton Transfer Weighted Brain Tumor Imaging With Compressed SENSE: Effects of Different Acceleration Factors.
    Zhang N; Zhang H; Gao B; Miao Y; Liu A; Song Q; Lin L; Wang J
    Front Neurosci; 2022; 16():876587. PubMed ID: 35692419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
    Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
    Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer imaging of human brain tumors at 3T.
    Jones CK; Schlosser MJ; van Zijl PC; Pomper MG; Golay X; Zhou J
    Magn Reson Med; 2006 Sep; 56(3):585-92. PubMed ID: 16892186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients.
    Tee YK; Harston GW; Blockley N; Okell TW; Levman J; Sheerin F; Cellerini M; Jezzard P; Kennedy J; Payne SJ; Chappell MA
    NMR Biomed; 2014 Sep; 27(9):1019-29. PubMed ID: 24913989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.
    Zhou J; Zhu H; Lim M; Blair L; Quinones-Hinojosa A; Messina SA; Eberhart CG; Pomper MG; Laterra J; Barker PB; van Zijl PC; Blakeley JO
    J Magn Reson Imaging; 2013 Nov; 38(5):1119-28. PubMed ID: 23440878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A; Gupta RK; Singh A
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amide proton transfer (APT) imaging of brain tumors at 7 T: The role of tissue water T
    Khlebnikov V; Polders D; Hendrikse J; Robe PA; Voormolen EH; Luijten PR; Klomp DW; Hoogduin H
    Magn Reson Med; 2017 Apr; 77(4):1525-1532. PubMed ID: 27060863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
    Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
    Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.
    Tietze A; Blicher J; Mikkelsen IK; Østergaard L; Strother MK; Smith SA; Donahue MJ
    NMR Biomed; 2014 Feb; 27(2):163-74. PubMed ID: 24288260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the effects of water proton concentration and water T
    Lee DH; Heo HY; Zhang K; Zhang Y; Jiang S; Zhao X; Zhou J
    Magn Reson Med; 2017 Feb; 77(2):855-863. PubMed ID: 26841096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.